Table 6.
Selection Criterion | Median PTH, pg/mL | Systolic Nocturnal Blood Pressure | Diastolic Nocturnal Blood Pressure | |||
---|---|---|---|---|---|---|
Adjusted β‐Coefficient | P Value | Adjusted β‐Coefficient | P Value | |||
NT‐proBNP, pg/mL | >85 | 49 (38–58) | 0.179 | .03 | 0.313 | <.01 |
<85 | 51 (40–51) | 0.078 | .4 | 0.002 | .99 | |
PAC, ng/dL | >15.5 | 52 (41–62)a | 0.149 | .10 | 0.198 | .03 |
<15.5 | 49 (37–61)a | 0.178 | .06 | 0.166 | .08 | |
eGFR, mL/min/m2 | ≥60 (n=234) | 49 (39–59) | 0.154 | .02 | 0.151 | .02 |
The multivariate linear regression analysis (model 3) was repeated in subgroups. Stratified analyses were based on median N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and plasma aldosterone concentration (PAC). Mann‐Whitney U test was used to calculate differences of parathyroid hormone (PTH) between subgroups. a P<.5.